{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:42:53Z","timestamp":1762173773310,"version":"build-2065373602"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07520-9","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:08:47Z","timestamp":1762168127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Magnitude and factors associated with virological failure among adults on first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia: a retrospective chart review"],"prefix":"10.1186","volume":"18","author":[{"given":"Kenesa Tesema","family":"Dibaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-5829","authenticated-orcid":false,"given":"Dumessa","family":"Edessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5790-7520","authenticated-orcid":false,"given":"Abera","family":"Cheru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4312-0136","authenticated-orcid":false,"given":"Melkamu Merid","family":"Mengesha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"7520_CR1","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach: World Health Organization; 2016."},{"key":"7520_CR2","doi-asserted-by":"crossref","unstructured":"Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000\u20132016. JAMA network open. 2020;3(6):e207954-e.","DOI":"10.1001\/jamanetworkopen.2020.7954"},{"issue":"10","key":"7520_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/hiv.12788","volume":"20","author":"A Brogan","year":"2019","unstructured":"Brogan A, Talbird S, Davis A, Wild L, Flanagan D. Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK. HIV Med. 2019;20(10):668\u201380.","journal-title":"HIV Med"},{"key":"7520_CR4","unstructured":"Organization WH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach: World Health Organization; 2016."},{"key":"7520_CR5","doi-asserted-by":"crossref","unstructured":"Weldegebreal F, Mitiku H, Teklemariam Z. Magnitude of adverse drug reaction and associated factors among HIV-infected adults on antiretroviral therapy in Hiwot Fana Specialized University Hospital, eastern Ethiopia. Pan African Medical Journal. 2016;24(1).","DOI":"10.11604\/pamj.2016.24.255.8356"},{"key":"7520_CR6","unstructured":"WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV: World Health Organization; 2015."},{"key":"7520_CR7","unstructured":"WHO. Patient monitoring guidelines for HIV care and ART. Geneva: WHO; 2006 2006."},{"key":"7520_CR8","unstructured":"WHO. Data quality assessment of national and partner HIV treatment and patient monitoring data and systems: implementation tool. World Health Organization; 2018."},{"key":"7520_CR9","unstructured":"UNAIDS. UNAIDS Global AIDS Update 2022. 2022."},{"key":"7520_CR10","unstructured":"HIV\/AIDS fact sheet. Geneva: World Health Organization; https:\/\/www.unaids.org\/en\/regionscountries\/countries\/ethiopia ; accessed on 27 June 2020 [Internet]. 2019 [cited 27 June 2020]. Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/ethiopia."},{"key":"7520_CR11","unstructured":"Ephi P. ICAP. Ethiopia population-based HIV impact assessment Ephia 2017\u20132018. Summary sheet: preliminary findings. 2018."},{"issue":"10","key":"7520_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164299","volume":"11","author":"D Haile","year":"2016","unstructured":"Haile D, Takele A, Gashaw K, Demelash H, Nigatu D. Predictors of treatment failure among adult antiretroviral treatment (ART) clients in bale zone hospitals, south-eastern Ethiopia. PLoS ONE. 2016;11(10):e0164299.","journal-title":"PLoS ONE"},{"key":"7520_CR13","first-page":"072","volume":"5","author":"T Agezew","year":"2019","unstructured":"Agezew T, Tadesse A, Derseh L, Yimer M. Incidence and predictors of first line anti-retroviral therapy failure among adults receiving HIV Care in North West Ethiopia: a hospital-based follow-up study. J Infect Dis Epidemiol. 2019;5:072.","journal-title":"J Infect Dis Epidemiol"},{"issue":"1","key":"7520_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2334-14-468","volume":"14","author":"A Assefa","year":"2014","unstructured":"Assefa A, Gelaw B, Getnet G, Yitayew G. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the University of Gondar Hospital, northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2014;14(1):468.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"7520_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2155-6113.1000749","volume":"8","author":"C Sisay","year":"2017","unstructured":"Sisay C, Bekele A, Sisay A, Mekonen H, Terfa K. Incidence and predictors of anti-retroviral treatment (ART) failure among adults Receiving HIV Care at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. J AIDS Clin Res. 2017;8(12):2.","journal-title":"J AIDS Clin Res"},{"issue":"1","key":"7520_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1186\/s12889-019-7078-5","volume":"19","author":"GA Lenjiso","year":"2019","unstructured":"Lenjiso GA, Endale BS, Bacha YD. Clinical and immunological failure among HIV-positive adults taking first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia. BMC Public Health. 2019;19(1):771.","journal-title":"BMC Public Health"},{"key":"7520_CR17","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: summary of key features and recommendations, June 2013. World Health Organization; 2013."},{"key":"7520_CR18","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1097\/QAD.0000000000000236","volume":"28","author":"GW Rutherford","year":"2014","unstructured":"Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, et al. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS. 2014;28:S161\u20139.","journal-title":"AIDS"},{"key":"7520_CR19","unstructured":"Tamrat Endebu, Alem Deksisa, Tibka Moges, Teresa Kisi, Ensermu T. Incidence of virological failure and associated factors among adult HIV-positive patients on first-line antiretroviral therapy regimen, Central Ethiopia. challenge. 2018;5:8."},{"issue":"1","key":"7520_CR20","first-page":"1","volume":"29","author":"P Kazooba","year":"2018","unstructured":"Kazooba P, Mayanja BN, Levin J, Masiira B, Kaleebu P. Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second-line therapy\u2013evidence from a prospective cohort study in rural South-Western Uganda, 2004\u20132011. Pan African Med J. 2018;29(1):1\u201316.","journal-title":"Pan African Med J"},{"issue":"2","key":"7520_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171780","volume":"12","author":"NTT Kyaw","year":"2017","unstructured":"Kyaw NTT, Harries AD, Kumar AM, Oo MM, Kyaw KWY, Win T, et al. High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005\u20132015. PLoS ONE. 2017;12(2):e0171780.","journal-title":"PLoS ONE"},{"issue":"1","key":"7520_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4732-6","volume":"20","author":"AA Desta","year":"2020","unstructured":"Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. HIV virological nonsuppression and factors associated with nonsuppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"7520_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017413","volume":"8","author":"HA Gesesew","year":"2018","unstructured":"Gesesew HA, Ward P, Woldemichael K, Mwangi L. Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(8):e017413.","journal-title":"BMJ Open"},{"key":"7520_CR24","doi-asserted-by":"crossref","unstructured":"Getaneh Y, Egziabhier AG, Zealiyas K, Tilahun R, Girma M, Michael GG, et al. Treatment failure among people living with HIV taking antiretroviral therapy in Ethiopia. BioRxiv. 2019:577049.","DOI":"10.1101\/577049"},{"issue":"4","key":"7520_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/pathogens8040161","volume":"8","author":"BT Tadesse","year":"2019","unstructured":"Tadesse BT, Chala A, Mukonzo J, Chaka TE, Tadesse S, Makonnen E, et al. Rates and correlates of short term virologic response among treatment-Na\u00efve HIV-infected children initiating antiretroviral therapy in Ethiopia: a multi-center prospective cohort study. Pathogens. 2019;8(4):161.","journal-title":"Pathogens"},{"key":"7520_CR26","doi-asserted-by":"crossref","unstructured":"Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DFJHA-R, et al. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case\u2012control study. 2017:153\u20139.","DOI":"10.2147\/HIV.S139516"},{"key":"7520_CR27","doi-asserted-by":"crossref","unstructured":"Ayalew MB, Kumilachew D, Belay A, Getu S, Teju D, Endale D, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. 2016:141\u20136.","DOI":"10.2147\/HIV.S112048"},{"key":"7520_CR28","doi-asserted-by":"crossref","unstructured":"Ayalew MB, Kumilachew D, Belay A, Getu S, Teju D, Endale D, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV\/AIDS-Research Palliative Care. 2016:141\u20136.","DOI":"10.2147\/HIV.S112048"},{"key":"7520_CR29","first-page":"8","volume":"5","author":"T Endebu","year":"2019","unstructured":"Endebu T, Deksisa A, Moges T, Kisi T, Ensermu T. Incidence of Virological failure and associated factors among adult HIV-positive patients on first-line antiretroviral therapy regimen. J Cen Ethiopia. 2019;5:8.","journal-title":"J Cen Ethiopia"},{"key":"7520_CR30","first-page":"1","volume":"16","author":"J Izudi","year":"2016","unstructured":"Izudi J, Alioni S, Kerukadho E, Ndungutse D. Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda. J BMC infectious diseases. 2016;16:1\u20138.","journal-title":"J BMC infectious diseases"},{"issue":"5","key":"7520_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196259","volume":"13","author":"GG Hailu","year":"2018","unstructured":"Hailu GG, Hagos DG, Hagos AK, Wasihun AG, Dejene TA. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS ONE. 2018;13(5):e0196259.","journal-title":"PLoS ONE"},{"key":"7520_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2428-3","volume":"17","author":"L Bulage","year":"2017","unstructured":"Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, et al. Factors associated with virological nonsuppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014\u2013July 2015. BMC Infect Dis. 2017;17:1\u201311.","journal-title":"BMC Infect Dis"},{"key":"7520_CR33","unstructured":"FMoH. National Guidelines for Comprehensive HIV Prevention, Care and Treatment; Ethiopian Ministry of Health. Addis Ababa2016."},{"key":"7520_CR34","unstructured":"Ess, IOM. Ministry of planning and development Ethiopia statistics service: statistical report on the 2021 labour force and migration survey. Available online at http:\/\/wwwstatsethiopiagovet\/wp-content\/uploads\/2022\/01\/Latest-STATISTICAL-REPORT-ON-THE-2021-LMS-3FEB20222pdf. (Accessed May 25, 2024). 2021."},{"issue":"1","key":"7520_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-020-00294-z","volume":"17","author":"J Nega","year":"2020","unstructured":"Nega J, Taye S, Million Y, Rodrigo C, Eshetie S. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia. AIDS Res Ther. 2020;17(1):1\u20139.","journal-title":"AIDS Res Ther"},{"key":"7520_CR36","doi-asserted-by":"crossref","unstructured":"Yan Zhao ZW, Jennifer M. McGoogan, Yiyi Sha, Decai Zhao, Ye Ma, Ron Brookmeyer, Roger Detels, and Julio S. G. Montaner. Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011\u20132015. Clinical Infectious Diseases 2019;68(1):43\u201350.","DOI":"10.1093\/cid\/ciy400"},{"key":"7520_CR37","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach: June 2013. Available online at https:\/\/wwwwhoint\/publications-detail-redirect\/9789241505727 (Accessed date May 27, 2024). 2013."},{"key":"7520_CR38","unstructured":"FMoH. National Guidelines for Comprehensive HIV Prevention, Care and Treatment; Ethiopian Ministry of Health. Addis Ababa2017."},{"key":"7520_CR39","doi-asserted-by":"crossref","unstructured":"Derseh BT, Shewayerga B, Dagnew Mekuria A, Admasu Basha E. Virological treatment failure among adult HIV\/AIDS patients from selected hospitals of North Shoa Zone, Amhara Region, Ethiopia. Infection Drug Resistance. 2020:4417\u201325.","DOI":"10.2147\/IDR.S280966"},{"issue":"4","key":"7520_CR40","first-page":"158","volume":"15","author":"T Haile","year":"2021","unstructured":"Haile T, Hawulte B, Alemayehu S. A retrospective cross-sectional study on the prevalence and factors associated with virological non suppression among HIV-positive adult patients on antiretroviral therapy in Woliso town, Oromia, Ethiopia. Int J Med Health Sci. 2021;15(4):158\u201364.","journal-title":"Int J Med Health Sci"},{"issue":"2","key":"7520_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211344","volume":"14","author":"F Kiweewa","year":"2019","unstructured":"Kiweewa F, Esber A, Musingye E, Reed D, Crowell TA, Cham F, et al. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study. PLoS ONE. 2019;14(2):e0211344.","journal-title":"PLoS ONE"},{"key":"7520_CR42","first-page":"393","volume":"12","author":"TF Wendie","year":"2020","unstructured":"Wendie TF, Workneh BD. Prevalence and predictors of virological failure among *adults living with HIV in South Wollo Zone, Northeast Ethiopia: a retrospective cohort study. HIV\/AIDS (Auckland, NZ). 2020;12:393.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"issue":"6","key":"7520_CR43","first-page":"385","volume":"3","author":"D Awoniyi","year":"2009","unstructured":"Awoniyi D, Udo S, Oguntibeju O. An epidemiological survey of neonatal sepsis in a hospital in western Nigeria. Afr J Microbiol Res. 2009;3(6):385\u20139.","journal-title":"Afr J Microbiol Res"},{"issue":"11","key":"7520_CR44","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/tmi.12563","volume":"20","author":"A Shet","year":"2015","unstructured":"Shet A, Neogi U, Kumarasamy N, DeCosta A, Shastri S, Rewari BB. Virological efficacy with first-line antiretroviral treatment in India: predictors of viral failure and evidence of viral suppression. Tropical Med Int Health. 2015;20(11):1462\u201372.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"7520_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4717-5","volume":"20","author":"D Yuan","year":"2020","unstructured":"Yuan D, Liu M, Jia P, Li Y, Huang Y, Ye L, et al. Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study. BMC Infect Dis. 2020;20(1):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"7520_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116144","volume":"10","author":"K Jobanputra","year":"2015","unstructured":"Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS ONE. 2015;10(2):e0116144.","journal-title":"PLoS ONE"},{"issue":"1","key":"7520_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4148-3","volume":"19","author":"G Dessie","year":"2019","unstructured":"Dessie G, Wagnew F, Mulugeta H, Amare D, Jara D, Leshargie CT, et al. The effect of disclosure on adherence to antiretroviral therapy among adults living with HIV in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7520_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10461-019-02456-1","volume":"24","author":"T Mi","year":"2020","unstructured":"Mi T, Li X, Zhou G, Qiao S, Shen Z, Zhou Y. Hiv disclosure to family members and medication adherence: role of social support and self-efficacy. AIDS Behav. 2020;24(1):45\u201354.","journal-title":"AIDS Behav"},{"issue":"3","key":"7520_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/hiv.13005","volume":"22","author":"E Morkphrom","year":"2021","unstructured":"Morkphrom E, Ratanasuwan W, Sittironnarit G, Rattanaumpawan P. Non-disclosure of HIV serostatus to sexual partners: prevalence, risk factors and clinical impact in patients with HIV. HIV Med. 2021;22(3):194\u2013200.","journal-title":"HIV Med"},{"key":"7520_CR50","first-page":"931","volume":"12","author":"IJ Abdullahi","year":"2020","unstructured":"Abdullahi IJ, Deybasso HA, Adlo AM. Determinants of virological failure among patients on first-line antiretroviral therapy in central Oromia, Ethiopia: a case-control study. HIV\/AIDS (Auckland, NZ). 2020;12:931.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"key":"7520_CR51","doi-asserted-by":"crossref","unstructured":"Yimer YT, Yalew AW. Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia. PLoS One. 2015;10(5):e0126026.","DOI":"10.1371\/journal.pone.0126026"},{"issue":"1","key":"7520_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-6405-11-1","volume":"11","author":"G Yonah","year":"2014","unstructured":"Yonah G, Fredrick F, Leyna G. HIV serostatus disclosure among people living with HIV\/AIDS in Mwanza. Tanzania AIDS Res Ther. 2014;11(1):1\u20135.","journal-title":"Tanzania AIDS Res Ther"},{"key":"7520_CR53","doi-asserted-by":"publisher","first-page":"205031212110301","DOI":"10.1177\/20503121211030182","volume":"9","author":"M Desalegn","year":"2021","unstructured":"Desalegn M, Seyoum D, Tola EK, Tsegaye GR. Determinants of first-line antiretroviral treatment failure among adult HIV patients at Nekemte Specialized Hospital, Western Ethiopia: unmatched case-control study. SAGE Open Med. 2021;9:20503121211030184.","journal-title":"SAGE Open Med"},{"issue":"9","key":"7520_CR54","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/jac\/dkv143","volume":"70","author":"M Rup\u00e9rez","year":"2015","unstructured":"Rup\u00e9rez M, Pou C, Maculuve S, Cede\u00f1o S, Luis L, Rodr\u00edguez J, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother. 2015;70(9):2639\u201347.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"7520_CR55","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1093\/jac\/dkw051","volume":"71","author":"C Hawkins","year":"2016","unstructured":"Hawkins C, Ulenga N, Liu E, Aboud S, Mugusi F, Chalamilla G, et al. HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults. J Antimicrob Chemother. 2016;71(7):1966\u201374.","journal-title":"J Antimicrob Chemother"},{"key":"7520_CR56","first-page":"153","volume":"9","author":"B Bayu","year":"2017","unstructured":"Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV\/AIDS (Auckland, NZ). 2017;9:153.","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"issue":"1","key":"7520_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00336-0","volume":"18","author":"A Mesic","year":"2021","unstructured":"Mesic A, Spina A, Mar HT, Thit P, Decroo T, Lenglet A, et al. Predictors of virological failure among people living with HIV receiving first-line antiretroviral treatment in Myanmar: retrospective cohort analysis. AIDS Res Ther. 2021;18(1):1\u201312.","journal-title":"AIDS Res Ther"},{"issue":"2","key":"7520_CR58","first-page":"345","volume":"5","author":"T Agezew","year":"2019","unstructured":"Agezew T, Tadesse A, Derseh L, Yimer M. Incidence and predictors of first-line anti-retroviral therapy failure among adults receiving HIV care in North West Ethiopia: a hospital-based follow-up study. Infect Dis Epidemiol. 2019;5(2):345.","journal-title":"Infect Dis Epidemiol"},{"issue":"10","key":"7520_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258930","volume":"16","author":"S Zenu","year":"2021","unstructured":"Zenu S, Tesema T, Reshad M, Abebe E. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case-control study. PLoS ONE. 2021;16(10):e0258930.","journal-title":"PLoS ONE"},{"key":"7520_CR60","first-page":"98","volume":"32","author":"F Sunkanmi","year":"2020","unstructured":"Sunkanmi F, Paul Y, Peter D, Nsikan A, Joseph J, Opada E, et al. Factors influencing viral load non suppression among people living with HIV (PLHIV) in Borno State, Nigeria: a case of Umaru Shehu Ultra-Modern Hospital. Adv Med Res. 2020;32:98\u2013105.","journal-title":"Adv Med Res"},{"issue":"1","key":"7520_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1952-x","volume":"16","author":"J Izudi","year":"2016","unstructured":"Izudi J, Alioni S, Kerukadho E, Ndungutse D. Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in northwestern Uganda. BMC Infect Dis. 2016;16(1):1\u20138.","journal-title":"BMC Infect Dis"},{"key":"7520_CR62","doi-asserted-by":"crossref","unstructured":"Abba A, Fokam J, Kamgaing RS, Yimga JF, Ka\u2019e AC, Nka AD, et al. Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon. PloS One. 2021;16(5):e0229550.","DOI":"10.1371\/journal.pone.0229550"},{"issue":"4","key":"7520_CR63","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/hiv.13017","volume":"22","author":"W Han","year":"2021","unstructured":"Han W, Jiamsakul A, Jantarapakde J, Yunihastuti E, Choi J, Ditangco R, et al. Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV. HIV Med. 2021;22(4):294\u2013306.","journal-title":"HIV Med"},{"key":"7520_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hiv.12708","volume":"20","author":"M Boyd","year":"2019","unstructured":"Boyd M, Boffito M, Castagna A, Estrada V. Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps. HIV Med. 2019;20:3\u201311.","journal-title":"HIV Med"},{"issue":"5","key":"7520_CR65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/QAD.0000000000002124","volume":"33","author":"S Coffey","year":"2019","unstructured":"Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, et al. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS (London, England). 2019;33(5):825.","journal-title":"AIDS (London, England)"},{"issue":"4","key":"7520_CR66","first-page":"282","volume":"33","author":"Z Chao","year":"2020","unstructured":"Chao Z, Wei Z, Rong LR, Lin O, Hui X, Ming SY, et al. Benefits of early and immediate initiation of antiretroviral therapy among HIV patients in Chongqing. China Biomed Environ Sci. 2020;33(4):282\u20135.","journal-title":"China Biomed Environ Sci"},{"issue":"9","key":"7520_CR67","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1056\/NEJMoa1904340","volume":"381","author":"Group NAS","year":"2019","unstructured":"Group NAS. Dolutegravir-based or low-dose efavirenz-based regimen for the treatment of HIV-1. N Engl J Med. 2019;381(9):816\u201326.","journal-title":"N Engl J Med"},{"issue":"9","key":"7520_CR68","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1902824","volume":"381","author":"WD Venter","year":"2019","unstructured":"Venter WD, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381(9):803\u201315.","journal-title":"N Engl J Med"},{"key":"7520_CR69","unstructured":"FMoH. National Guidelines for Comprehensive HIV Prevention, Care and Treatment; Ethiopian Ministry of Health. Addis Ababa2018."},{"issue":"2","key":"7520_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"HF G\u00fcnthard","year":"2016","unstructured":"G\u00fcnthard HF, Saag MS, Benson CA, Del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society\u2013USA panel. JAMA. 2016;316(2):191\u2013210.","journal-title":"JAMA"},{"issue":"3","key":"7520_CR71","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1016\/S2352-3018(19)30400-X","volume":"7","author":"AN Phillips","year":"2020","unstructured":"Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, et al. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines. The Lancet HIV. 2020;7(3):e193\u2013200.","journal-title":"The Lancet HIV"},{"issue":"11","key":"7520_CR72","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1086\/522991","volume":"45","author":"HO Ramadhani","year":"2007","unstructured":"Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F, Kirchherr JL, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45(11):1492\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07520-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07520-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:04:22Z","timestamp":1762171462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07520-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7520"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07520-9","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Institutional Health Research Ethics Review Committee of the Haramaya University College of Health and Medical Sciences (Ref. No. IHRERC\/259\/2020). In addition, a support letter was obtained from the Dire Dawa Administration Health Bureau and communicated to ART centres. The names of patients were not recorded, and their unique MRN numbers were locked for confidentiality. The need for written and informed consent to participate was waived by the Institutional Health Research Ethics Review Committee of the Haramaya University College of Health and Medical Sciences because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"464"}}